StockData
BioAdaptives, Inc. logo

BioAdaptives, Inc. (BDPT) stock

BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.00−0.00 (-5.56%)

Close on Oct 19, 2026Market cap $478.03KP/E –Yield –

BioAdaptives net income

Net income is the profit left for shareholders after every expense, interest and tax.

BioAdaptives's net income for the twelve months ending Jun 30, 2026 was -$1.16M. For fiscal 2025 it was -$1.56M. The highest annual figure on record is -$227.43K in fiscal 2015.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.56M–
FY2024Dec 31, 2024-$899.16K–
FY2023Dec 31, 2023-$712.47K–
FY2022Dec 31, 2022-$895.57K–
FY2021Dec 31, 2021-$1.05M–
FY2020Dec 31, 2020-$847.24K–
FY2019Dec 31, 2019-$238.93K–
FY2018Dec 31, 2018-$1.41M–
FY2015Dec 31, 2015-$227.43K–
FY2014Dec 31, 2014-$2.58M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$150.09K–
Q1 FY2026Mar 31, 2026-$111.09K–
Q4 FY2025Dec 31, 2025-$823.35K–
Q3 FY2025Sep 30, 2025-$379.50K–
Q2 FY2025Jun 30, 2025-$157.91K–
Q1 FY2025Mar 31, 2025-$197.14K–
Q4 FY2024Dec 31, 2024-$371.79K–
Q3 FY2024Sep 30, 2024-$37.65K–
Q2 FY2024Jun 30, 2024-$183.02K–
Q1 FY2024Mar 31, 2024-$306.71K–
Q4 FY2023Dec 31, 2023-$268.30K–
Q3 FY2023Sep 30, 2023-$13.06K–
Q2 FY2023Jun 30, 2023-$143.92K–
Q1 FY2023Mar 31, 2023-$287.19K–
Q4 FY2022Dec 31, 2022-$28.28K–
Q3 FY2022Sep 30, 2022-$276.33K–
Q2 FY2022Jun 30, 2022-$223.84K–
Q1 FY2022Mar 31, 2022-$367.13K–
Q4 FY2021Dec 31, 2021-$214.28K–
Q3 FY2021Sep 30, 2021-$34.52K–
Q2 FY2021Jun 30, 2021-$309.25K–
Q1 FY2021Mar 31, 2021-$491.90K–
Q4 FY2020Dec 31, 2020-$165.42K–
Q3 FY2020Sep 30, 2020-$13.46K–
Q2 FY2020Jun 30, 2020-$430.44K–
Q1 FY2020Mar 31, 2020-$237.92K-357.4%
Q4 FY2019Dec 31, 2019-$96.60K–
Q3 FY2019Sep 30, 2019-$54.91K–
Q2 FY2019Jun 30, 2019-$179.87K–
Q1 FY2019Mar 31, 2019$92.45K–
Q4 FY2018Dec 31, 2018-$336.19K–
Q3 FY2018Sep 30, 2018-$648.60K–
Q2 FY2018Jun 30, 2018-$412.78K–
Q1 FY2018Mar 31, 2018-$9.10K–
Q3 FY2016Sep 30, 2016-$26.31K–
Q2 FY2016Jun 30, 2016-$33.21K–
Q1 FY2016Mar 31, 2016-$80.92K–
Q4 FY2015Dec 31, 2015-$48.51K–
Q3 FY2015Sep 30, 2015-$40.14K–

More BioAdaptives figures

See a number that looks wrong?